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1. Introduction
   Periodontitis is a highly prevalent oral disease among 
adults that results from inflammation of the supporting 
structures of the teeth[1]. Though microbial etiology has been 
proposed in recent research emphasizing that host tissue 
destruction is mainly an injury produced by the cytokines 
due to their non specific nature[2]. The cytokines which 
disseminate from the periodontium can affect or influence 
the other body systems[3-5]. Conversely inflammatory 
cytokines produced elsewhere can also influence the 
periodontium[6,7]. These studies prove the fact that 
periodontium can no more be considered as an individual 
unit but a dynamic organ which constantly interacts with 
the body system.
   Hansen’s disease or leprosy is chronic granulomatous 
disease caused by the bacteria Mycobacterium leprae, an 
acid fast and obligate inter cellular pathogen. It was first 
identified by Hansen in 1873 with two extrem epolar forms, 
namely, tuberculoid and lepromatous ranging in severity, 
even though a spectrum types seen between these two polar 
forms[8]. This variation in clinical expression is mainly 
attributed to the differences in host mediated immune 
response[9].
   Although both cellular and humoral immune pathways 
are mounted against this organism to ward off the infection, 
it is the cellular immunity that plays the major role in 
protecting the affected individuals, and the derangement of 
which leads to down-hill progression of the disease from 
tuberculoid to lepromatous type. 
   Hence many similarities can be seen between periodontitis 
and leprosy. Both of them are chronic, displaying inter 
individual differences in the clinical expression of the 
disease, extremely dependent on host mounted immune 
response (with respect to clinical manifestations) and role 
of cytokines in the pathogenesis of both the diseases. The 
above said similarities raise a question which can be an 
association between these two diseases or not as they share 
many pathological features. 
   Although oral manifestations of leprosy have been 
reported with rare incidence[10], the periodontal status 
in lepers has not been studied clearly. There are only 
countable studies addressing this issue[11-13]. Hence, the 
present study was undertaken to analyze the relationship 
between these two diseases with the aim being to identify 
the difference in periodontal status between healthy 
individuals and patients with Hansen’s disease.
2. Materials and methods
   The study group comprised of 50 individuals who are 
diagnosed to have leprosy and 50 healthy individuals who 
Objective: To find out whether there are any relationship between leprosy and periodontitis as 
evidenced by clinical parameters.
Methods: Fifteen diagnosed patients with Hansen’s disease were selected and compared against 
50 healthy individuals. Clinical parameters like probing pocket depth and clinical attachment 
level were evaluated for both the groups and the results were subjected to statistical analysis. 
Results: Mean probing depth and attachment loss is seen more in patients with Hansen’s disease 
than the healthy controls which are statistically significant.
Conclusions: Patients with Hansen’s disease tend to have more periodontal destruction than the 
healthy controls.
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served as controls. All the patients were recruited from the 
outpatient department of Tamilnadu Goverenment Dental 
College, Chennai in India. The study was conducted from 
March 2007 to December 2007. All the lepers were under anti 
leprosy therapy (dapsone or clofazimine or both). Patients 
who are diagnosed to have leprosy are allowed to participate 
in this study. Additional inclusion criteria includes presence 
of at least twenty teeth, excluding third molars, good or 
fair oral hygiene (as determined by taking Simplified Oral 
Hygiene Index at the time of patient selection[14], by a 
single examiner) and otherwise healthy systemically. Same 
criteria were used to select controls with the exception that 
they are leprosy negative. Both the sexes were allowed to 
participate in this study. Exclusion criteria includes history 
of oral prophylaxis or any other dental treatment in the past 
6 months, usage of antibiotics in the past 3 months (except 
antileprotic drugs for cases), smokers, pregnant females, 
history of any other systematic disease.
   Both the selected cases and controls were subjected 
to an oral examination which included the evaluation of 
their periodontal status as estimated by measuring probing 
depth (PD) and clinical attachment level (CAL). PD and CAL 
were assessed using a probe with William’s marking in 
both the arches. All the six sites per tooth were assessed. 
Other significant periodontal finding, if present was also 
noted. Cases were also examined for the presence of facial 
destruction and mutilation of digits. The results were 
analyzed by using SPSS system. ANOVA was the statistical 
test used to determine difference between the groups, 
considering P value less than or equal to 0.05 as significant.
3. Results
   The age range of the study group was 20-65 years in 
cases and 22-64 years in controls. There were 24 males 
and 26 females, and 27 males and 23 females in cases and 
control, respectively. Values expressed as mean依SD about 
demographic variables of cases and controls were 39.86依
14.61 and 38.66依11.18, respectively. Cases were divided into 
6 types: tuberculoid (40%), borderline tuberculoid (13%), 
borderline (3%), indeterminate (1%), borderline lepromatous 
(8%) and lepromatous (35%)[15]. Mean of PD and CAL, when 
compared between cases and controls, was seen more 
statistically significant in the cases than in the controls in 
Table 1 and in both the arches and there was no difference 
in the periodontal status of people taking dapsone or 
clofazimine or both.
Table 1
Periodontal status between the two groups.
Parameter Cases Control P value
PD Maxilla 1.95依0.64 1.55依0.30 0.000
*
Mandible 2.01依0.54 1.52依0.27 0.000
*
CAL Maxilla 1.55依0.38 0.49依0.65 0.000
*
Mandible 1.59依0.22 0.62依0.81 0.000
*           
*: Statistically significant differences at P<0.05. Values in cases and control 
are expressed as mean依SD.
   None of our patients exhibited midface destruction or 
mutilation of digits. Similarly, no other pathologic oral 
findings like leprotic nodules were seen.
4. Discussion
   Though, microbial etiology has been proposed, host 
response mounted by an individual is responsible for the 
tissue destruction seen in chronic periodontitis[2]. This 
aspect is also noted in the leprosy, in which the varied 
clinical expression is due to the difference in the host 
response mounted by an individual[9]. This along with other 
common features like chronicity, involvement of cytokines 
in the pathogenesis of the diseases as mentioned earlier was 
the rationale behind conducting this study.
   Literature search revealed limited data with respect to 
the relationship between leprosy and periodontitis. These 
studies were all done in different population and to the 
best of our knowledge this is the first study done in our 
population, and it was proved invariably that there exist 
relationship between these two chronic diseases[11-13], and 
our study is of no exception. Our study included subjects 
under anti-leprotic drugs to know the effect of these drugs 
on the periodontal disease pathogenesis as they are all 
potent immune-modulators. 
   Our study comprised of healthy individuals who are 
systemically healthy and cases who are positive for 
Mycobacterium leprae. Cases were again stratified according 
to the type of leprosy. Since the number of individuals in 
each group was less; correlation was not made and the 
entire group (cases) was compared against controls. Our 
study results showed a positive correlation between leprosy 
and periodontitis which is in accordance with the other 
studies[12]. In the study conducted by Núñez-Martí et al.[12], 
only the anterior maxilla was compared between the cases 
and controls and no attempt was made to compare the 
periodontal status in other regions. Our study showed that 
both maxilla and mandible can be equally affected along 
with any other systematic disease involving periodontium, 
though the attachment loss is slightly more in mandible 
than in maxilla. Since our primary aim was to identify the 
relationship between these two diseases, we compared 
the periodontal status taking maxilla and mandible as a 
whole, as dividing each arch into segments might not reveal 
the exact nature of the disease. In the study conducted 
by Souza et al.[13], association was shown between the 
two diseases. But, the parameter employed to assess the 
periodontal disease is only probing depth and details 
about the attachment level are not given. As attachment 
level is considered as a gold standard for diagnosing 
periodontitis[16]; we used attachment level as the marker 
to diagnose periodontitis and it was found that cases have 
more loss than the controls which was also statistically 
significant.
   The plausible explanation that can be given for these 
results is the involvement of cytokines producing the 
clinical lesion in both the diseases. Leprosy is not only 
an infectious disease, but also have an immunological 
component. Even though tuberculoid form showed humoral 
mediated immune response, it does not help much in 
preventing the tissue destruction. It is the cell mediated 
immunity that plays a protective role in initial cases, the 
derangement occurs as the disease progresses leading to 
tissue destruction seen in lepromatous forms[9]. In these 
two polar forms, there are other intermediate forms which 
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show a variable immune response that can differ from one 
individual to another.The pathogenesis of the disease also 
involves the extensive presence of cytokines like tumour 
necrosis factor (TNF)-α, interleukin-6, interleukin (IL)-1, 
which are responsible for both disease progression and 
tissue destruction[17-21].
   The role of pro-inflammatory cytokines like TNF-α and 
IL-β in the pathogenesis of periodontitis cannot be over 
emphasized since their role has been clearly proved over the 
past few decades[2]. These cytokines can be originated from 
local sources or produced from an inflammatory process 
in another organ systems, and reach the periodontium 
thereby leading to a worsening of periodontal destruction. 
The later route is proved with systematic diseases like 
diabetes mellitus[6,7], which can influence periodontal 
disease expression. Thus leprosy can be kept in line next to 
above said disease which can alter the periodontal disease 
progression.
   Our study results show that there is an increasing risk 
for lepers to get periodontitis or worsening of an existing 
periodontitis, but the exact role or mechanism is yet to 
be determined. Our study results do not say whether 
this increased risk is only due to the immunological 
commonality, or it is due to the combined effect of the 
organism in the biofilm and the immune response mounted 
against the organism, which are the main limitations of 
this study. Hence further longitudinal studies are required 
to identify the periodontal disease progression in lepers 
to know whether periodontitis in these patients behavior 
like chronic periodontitis or in an aggressive manner. 
Additionally, cytokine profiles need to be assessed to prove 
the above said mechanism. Hence, within the limits of this 
study, it can be concluded that leprotic individuals might 
be more susceptible to periodontal destruction than the 
healthy individuals. Patients with leprosy tend to have more 
periodontal disease than the healthy individuals.
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